Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1413

1.

Palladium Mediated Cleavage of Thiazolidine Backbone Modified Proteins in Live Cells.

Brik A, Mann G, Satish G, Meledin R, Vamisetti GB.

Angew Chem Int Ed Engl. 2019 Aug 11. doi: 10.1002/anie.201906545. [Epub ahead of print]

PMID:
31402546
2.

College2Youth: Design of Multidisciplinary Interdisciplinary Undergraduate Research Experience.

Mann G, Bishop TU, Kaiser K, Cafer A.

J Nutr Educ Behav. 2019 Aug 8. pii: S1499-4046(19)30926-1. doi: 10.1016/j.jneb.2019.07.009. [Epub ahead of print] No abstract available.

PMID:
31402289
3.

Improving breast cancer screening in Australia: a public health perspective.

Nickson C, Velentzis LS, Brennan P, Mann GB, Houssami N.

Public Health Res Pract. 2019 Jul 31;29(2). pii: 2921911. doi: 10.17061/phrp2921911.

4.

Development and external validation study of a melanoma risk prediction model incorporating clinically-assessed naevi and solar lentigines.

Vuong K, Armstrong BK, Drummond M, Hopper JL, Barrett JH, Davies JR, Bishop DT, Newton-Bishop J, Aitken JF, Giles GG, Schmid H, Jenkins MA, Mann GJ, McGeechan K, Cust AE.

Br J Dermatol. 2019 Aug 4. doi: 10.1111/bjd.18411. [Epub ahead of print]

PMID:
31378928
5.

Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.

Enomoto LM, Choudry MH, Bartlett DL, Totin L, Mann GN, Skitzki JJ, Perry KC, Votanopoulos KI, Levine EA, Shen P.

Ann Surg Oncol. 2019 Jul 31. doi: 10.1245/s10434-019-07634-y. [Epub ahead of print]

PMID:
31368017
6.

Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia.

Galimberti S, Devidas M, Lucenti A, Cazzaniga G, Möricke A, Bartram CR, Mann G, Carroll W, Winick N, Borowitz M, Wood B, Basso G, Conter V, Zimmermann M, Suciu S, Biondi A, Schrappe M, Hunger SP, Valsecchi MG.

JNCI Cancer Spectr. 2018 Dec 19;2(4):pky069. doi: 10.1093/jncics/pky069. eCollection 2018 Oct.

7.

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.

Newell F, Kong Y, Wilmott JS, Johansson PA, Ferguson PM, Cui C, Li Z, Kazakoff SH, Burke H, Dodds TJ, Patch AM, Nones K, Tembe V, Shang P, van der Weyden L, Wong K, Holmes O, Lo S, Leonard C, Wood S, Xu Q, Rawson RV, Mukhopadhyay P, Dummer R, Levesque MP, Jönsson G, Wang X, Yeh I, Wu H, Joseph N, Bastian BC, Long GV, Spillane AJ, Shannon KF, Thompson JF, Saw RPM, Adams DJ, Si L, Pearson JV, Hayward NK, Waddell N, Mann GJ, Guo J, Scolyer RA.

Nat Commun. 2019 Jul 18;10(1):3163. doi: 10.1038/s41467-019-11107-x.

8.

PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories.

Schiefer AI, Salzer E, Füreder A, Szepfalusi Z, Müller-Sacherer T, Huber WD, Michel-Behnke I, Lawitschka A, Pichler H, Mann G, Hutter C, Simonitsch-Klupp I, Attarbaschi A.

Cancer Med. 2019 Jul 3. doi: 10.1002/cam4.2394. [Epub ahead of print]

9.

Data independent acquisition proteomic analysis can discriminate between actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma.

Azimi A, Yang P, Ali M, Howard V, Mann GJ, Kaufman KL, Fernandez-Penas P.

J Invest Dermatol. 2019 Jun 26. pii: S0022-202X(19)31794-4. doi: 10.1016/j.jid.2019.06.128. [Epub ahead of print]

PMID:
31254517
10.

Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.

Dieng M, Khanna N, Kasparian NA, Costa DSJ, Butow PN, Menzies SW, Mann GJ, Cust AE, Morton RL.

Appl Health Econ Health Policy. 2019 Jun 21. doi: 10.1007/s40258-019-00483-6. [Epub ahead of print]

PMID:
31228015
11.

Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature.

Hernandez-Diaz I, Pan J, Ricciardi CA, Bai X, Ke J, White KE, Flaquer M, Fouli GE, Argunhan F, Hayward AE, Hou FF, Mann GE, Miao RQ, Long DA, Gnudi L.

Diabetes. 2019 Jun 19. pii: db190157. doi: 10.2337/db19-0157. [Epub ahead of print]

PMID:
31217174
12.

Evaluation of progestogen supplementation for luteal phase support in fresh in vitro fertilization cycles.

Mohammed A, Woad KJ, Mann GE, Craigon J, Raine-Fenning N, Robinson RS.

Fertil Steril. 2019 Jun 11. pii: S0015-0282(19)30396-6. doi: 10.1016/j.fertnstert.2019.04.021. [Epub ahead of print]

PMID:
31200970
13.

The association between weight perception and weight intention in middle school Appalachian students.

Mann G, Serrano E.

Public Health. 2019 Jun;171:135-138. doi: 10.1016/j.puhe.2019.04.007. Epub 2019 May 24.

PMID:
31132516
14.

Impact of endometritis on post-partum ovarian cyclicity in dairy cows.

Mohammed ZA, Mann GE, Robinson RS.

Vet J. 2019 Jun;248:8-13. doi: 10.1016/j.tvjl.2019.03.008. Epub 2019 Mar 26.

PMID:
31113569
15.

Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure.

Cust AE, Drummond M, Bishop DT, Azizi L, Schmid H, Jenkins MA, Hopper JL, Armstrong BK, Aitken JF, Kefford RF, Giles GG, Demenais F, Goldstein AM, Barrett JH, Kanetsky PA, Elder DE, Mann GJ, Newton-Bishop JA.

J Eur Acad Dermatol Venereol. 2019 May 13. doi: 10.1111/jdv.15680. [Epub ahead of print]

16.

Right on track? Performance of satellite telemetry in terrestrial wildlife research.

Hofman MPG, Hayward MW, Heim M, Marchand P, Rolandsen CM, Mattisson J, Urbano F, Heurich M, Mysterud A, Melzheimer J, Morellet N, Voigt U, Allen BL, Gehr B, Rouco C, Ullmann W, Holand Ø, Jørgensen NH, Steinheim G, Cagnacci F, Kroeschel M, Kaczensky P, Buuveibaatar B, Payne JC, Palmegiani I, Jerina K, Kjellander P, Johansson Ö, LaPoint S, Bayrakcismith R, Linnell JDC, Zaccaroni M, Jorge MLS, Oshima JEF, Songhurst A, Fischer C, Mc Bride RT Jr, Thompson JJ, Streif S, Sandfort R, Bonenfant C, Drouilly M, Klapproth M, Zinner D, Yarnell R, Stronza A, Wilmott L, Meisingset E, Thaker M, Vanak AT, Nicoloso S, Graeber R, Said S, Boudreau MR, Devlin A, Hoogesteijn R, May-Junior JA, Nifong JC, Odden J, Quigley HB, Tortato F, Parker DM, Caso A, Perrine J, Tellaeche C, Zieba F, Zwijacz-Kozica T, Appel CL, Axsom I, Bean WT, Cristescu B, Périquet S, Teichman KJ, Karpanty S, Licoppe A, Menges V, Black K, Scheppers TL, Schai-Braun SC, Azevedo FC, Lemos FG, Payne A, Swanepoel LH, Weckworth BV, Berger A, Bertassoni A, McCulloch G, Šustr P, Athreya V, Bockmuhl D, Casaer J, Ekori A, Melovski D, Richard-Hansen C, van de Vyver D, Reyna-Hurtado R, Robardet E, Selva N, Sergiel A, Farhadinia MS, Sunde P, Portas R, Ambarli H, Berzins R, Kappeler PM, Mann GK, Pyritz L, Bissett C, Grant T, Steinmetz R, Swedell L, Welch RJ, Armenteras D, Bidder OR, González TM, Rosenblatt A, Kachel S, Balkenhol N.

PLoS One. 2019 May 9;14(5):e0216223. doi: 10.1371/journal.pone.0216223. eCollection 2019.

17.

Paracetamol overdose complicated by posterior reversible encephalopathy syndrome (PRES).

Mann G, Gunja N.

Clin Toxicol (Phila). 2019 May 3:1-2. doi: 10.1080/15563650.2019.1609023. [Epub ahead of print] No abstract available.

PMID:
31046475
18.

Melanoma Explorer: a web application to allow easy reanalysis of publicly available and clinically annotated melanoma omics data sets.

Strbenac D, Wang K, Wang X, Dong J, Mann GJ, Mueller S, Yang JYH.

Melanoma Res. 2019 Jun;29(3):342-344. doi: 10.1097/CMR.0000000000000533.

PMID:
31026248
19.

"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.

Lippey J, Keogh LA, Mann GB, Campbell IG, Forrest LE.

Cancer Prev Res (Phila). 2019 Jun;12(6):383-390. doi: 10.1158/1940-6207.CAPR-18-0443. Epub 2019 Apr 19.

PMID:
31003994
20.

Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial.

Dieng M, Morton RL, Costa DSJ, Butow PN, Menzies SW, Lo S, Mann GJ, Cust AE, Kasparian NA.

Br J Dermatol. 2019 Apr 9. doi: 10.1111/bjd.17990. [Epub ahead of print]

PMID:
30965384
21.

Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result.

Stafford L, Flehr A, Judd F, Lindeman GJ, Gibson P, Komiti A, Mann GB, Kentwell M.

J Community Genet. 2019 Mar 27. doi: 10.1007/s12687-019-00415-w. [Epub ahead of print]

PMID:
30919324
22.

Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures.

Bromley HL, Petrie D, Mann GB, Nickson C, Rea D, Roberts TE.

Soc Sci Med. 2019 May;228:142-154. doi: 10.1016/j.socscimed.2019.03.028. Epub 2019 Mar 21. Review.

PMID:
30913528
23.

Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite Interactions.

Taylor MC, Francisco AF, Jayawardhana S, Mann GS, Ward AI, Olmo F, Lewis MD, Kelly JM.

Methods Mol Biol. 2019;1955:147-163. doi: 10.1007/978-1-4939-9148-8_11.

PMID:
30868525
24.

Minimally Invasive Esophageal Cancer Surgery.

Peng JS, Kukar M, Mann GN, Hochwald SN.

Surg Oncol Clin N Am. 2019 Apr;28(2):177-200. doi: 10.1016/j.soc.2018.11.009. Epub 2019 Feb 2. Review.

PMID:
30851822
25.

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas.

Quek C, Rawson RV, Ferguson PM, Shang P, Silva I, Saw RPM, Shannon K, Thompson JF, Hayward NK, Long GV, Mann GJ, Scolyer RA, Wilmott JS.

Oncotarget. 2019 Jan 29;10(9):930-941. doi: 10.18632/oncotarget.26584. eCollection 2019 Jan 29.

26.

Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.

Kader T, Hill P, Zethoven M, Goode DL, Elder K, Thio N, Doyle M, Semple T, Sufyan W, Byrne DJ, Pang JB, Murugasu A, Miligy IM, Green AR, Rakha EA, Fox SB, Mann GB, Campbell IG, Gorringe KL.

J Pathol. 2019 Jul;248(3):326-338. doi: 10.1002/path.5262. Epub 2019 Apr 22.

PMID:
30843206
27.

Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center.

Poyer F, Friesenbichler W, Hutter C, Pichler H, Dworzak M, Peters C, Mann G, Indra A, Attarbaschi A.

Pediatr Blood Cancer. 2019 Jul;66(7):e27691. doi: 10.1002/pbc.27691. Epub 2019 Mar 1.

PMID:
30825249
28.

Molecular Genomic Profiling of Melanocytic Nevi.

Colebatch AJ, Ferguson P, Newell F, Kazakoff SH, Witkowski T, Dobrovic A, Johansson PA, Saw RPM, Stretch JR, McArthur GA, Long GV, Thompson JF, Pearson JV, Mann GJ, Hayward NK, Waddell N, Scolyer RA, Wilmott JS.

J Invest Dermatol. 2019 Aug;139(8):1762-1768. doi: 10.1016/j.jid.2018.12.033. Epub 2019 Feb 14.

PMID:
30772300
29.

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2019 Feb;566(7745):E11-E12. doi: 10.1038/s41586-019-0974-0.

PMID:
30755741
30.

Molecular comparison of interval and screen-detected breast cancers.

Cheasley D, Li N, Rowley SM, Elder K, Mann GB, Loi S, Savas P, Goode DL, Kader T, Zethoven M, Semple T, Fox SB, Pang JM, Byrne D, Devereux L, Nickson C, Procopio P, Lee G, Hughes S, Saunders H, Fujihara KM, Kuykhoven K, Connaughton J, James PA, Gorringe KL, Campbell IG.

J Pathol. 2019 Jun;248(2):243-252. doi: 10.1002/path.5251. Epub 2019 Mar 8.

PMID:
30746706
31.

Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.

Taylor NJ, Mitra N, Qian L, Avril MF, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Gruis NA, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Mann GJ, Nagore E, Olsson H, Palmer JM, Perić B, Pjanova D, Pritchard AL, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Yang XR, Newton-Bishop JA, Kanetsky PA; GenoMEL Study Group.

J Am Acad Dermatol. 2019 Aug;81(2):386-394. doi: 10.1016/j.jaad.2019.01.079. Epub 2019 Feb 5.

PMID:
30731170
32.

CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia.

Schumich A, Zaliova M, Fortschegger K, Nebral K, Attarbaschi A, Fiser K, Kauer MO, Popitsch N, Haslinger S, Inthal A, Buldini B, Basso G, Bourquin JP, Gaipa G, Brüggemann M, Feuerstein T, Maurer-Granofszky M, Panzer-Grümayer R, Trka J, Mann G, Haas OA, Hrusak O, Dworzak MN, Strehl S.

Haematologica. 2019 Aug;104(8):e352-e355. doi: 10.3324/haematol.2018.214353. Epub 2019 Jan 31. No abstract available.

33.

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Lo LL, Collins IM, Bressel M, Butow P, Emery J, Keogh L, Weideman P, Steel E, Hopper JL, Trainer AH, Mann GB, Bickerstaffe A, Antoniou AC, Cuzick J, Phillips KA.

JMIR Form Res. 2018 Nov 7;2(2):e24. doi: 10.2196/formative.9935.

34.

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.

Zhao X, Little P, Hoyle AP, Pegna GJ, Hayward MC, Ivanova A, Parker JS, Marron DL, Soloway MG, Jo H, Salazar AH, Papakonstantinou MP, Bouchard DM, Jefferys SR, Hoadley KA, Ollila DW, Frank JS, Thomas NE, Googe PB, Ezzell AJ, Collichio FA, Lee CB, Earp HS, Sharpless NE, Hugo W, Wilmott JS, Quek C, Waddell N, Johansson PA, Thompson JF, Hayward NK, Mann GJ, Lo RS, Johnson DB, Scolyer RA, Hayes DN, Moschos SJ.

Front Oncol. 2019 Jan 4;8:584. doi: 10.3389/fonc.2018.00584. eCollection 2018.

35.

Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.

Pires da Silva I, Wang KYX, Wilmott JS, Holst J, Carlino MS, Park JJ, Quek C, Wongchenko M, Yan Y, Mann G, Johnson DB, McQuade JL, Rai R, Kefford RF, Rizos H, Scolyer RA, Yang JYH, Long GV, Menzies AM.

Clin Cancer Res. 2019 Feb 15;25(4):1272-1279. doi: 10.1158/1078-0432.CCR-18-1680. Epub 2019 Jan 10.

PMID:
30630828
36.

Standardization of perioperative care facilitates safe discharge by postoperative day five after pancreaticoduodenectomy.

Daniel SK, Thornblade LW, Mann GN, Park JO, Pillarisetty VG.

PLoS One. 2018 Dec 28;13(12):e0209608. doi: 10.1371/journal.pone.0209608. eCollection 2018.

37.

Model predictive controller-based spatiotemporal path tracking method for transhumeral prostheses.

Dannangoda Gamage KM, Gopura RARC, Amarasinghe YWR, Mann GKI.

Int J Med Robot. 2019 Jun;15(3):e1980. doi: 10.1002/rcs.1980. Epub 2019 Jan 9.

PMID:
30588729
38.

Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.

Nickson C, Procopio P, Velentzis LS, Carr S, Devereux L, Mann GB, James P, Lee G, Wellard C, Campbell I.

Breast Cancer Res. 2018 Dec 20;20(1):155. doi: 10.1186/s13058-018-1084-x.

39.

Treatment Intensity Differences According to Participation in a Population Screening Program.

Mann GB, Nickson C, Elder K.

Ann Surg Oncol. 2019 Feb;26(2):698-699. doi: 10.1245/s10434-018-07113-w. Epub 2018 Dec 18. No abstract available.

PMID:
30565041
40.

Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.

Schumich A, Maurer-Granofszky M, Attarbaschi A, Pötschger U, Buldini B, Gaipa G, Karawajew L, Printz D, Ratei R, Conter V, Schrappe M, Mann G, Basso G, Dworzak MN; AIEOP-BFM-ALL-FLOW-Study Group.

Pediatr Blood Cancer. 2019 May;66(5):e27590. doi: 10.1002/pbc.27590. Epub 2018 Dec 18.

PMID:
30561169
41.

RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes.

Guo D, Lui GYL, Lai SL, Wilmott JS, Tikoo S, Jackett LA, Quek C, Brown DL, Sharp DM, Kwan RYQ, Chacon D, Wong JH, Beck D, van Geldermalsen M, Holst J, Thompson JF, Mann GJ, Scolyer RA, Stow JL, Weninger W, Haass NK, Beaumont KA.

Int J Cancer. 2019 Jun 15;144(12):3070-3085. doi: 10.1002/ijc.32064. Epub 2019 Jan 3.

PMID:
30556600
42.

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.

Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, Liew D, Liu HK, Mann GB, Moodie K, Murugasu A, Pal B, Roberts AW, Rosenthal MA, Shackleton K, Silva MJ, Siow ZR, Smyth GK, Taylor L, Travers A, Yeo B, Yeung MM, Bujak AZ, Dawson SJ, Gray DHD, Visvader JE, Lindeman GJ.

Cancer Discov. 2019 Mar;9(3):354-369. doi: 10.1158/2159-8290.CD-18-1151. Epub 2018 Dec 5.

PMID:
30518523
43.

Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations.

Jongen L, Floris G, Boeckx B, Smeets D, Lambrechts D, Vander Borght S, Laenen A, Mann G, Cutler RE Jr, Lalani AS, Neven P, Wildiers H.

Breast Cancer Res Treat. 2019 Feb;174(1):55-63. doi: 10.1007/s10549-018-5049-7. Epub 2018 Nov 19.

PMID:
30456437
44.

Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2019 Feb;43:39-47. doi: 10.1016/j.breast.2018.11.002. Epub 2018 Nov 7.

PMID:
30445378
45.

ASO Author Reflections: Impact of Breast Cancer Screening Beyond Mortality Reductions.

Elder K, Nickson C, Mann GB.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):687-688. doi: 10.1245/s10434-018-7001-9. Epub 2018 Nov 9. No abstract available.

PMID:
30414033
46.

Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy.

Nahm CB, Lui I, Naidoo CS, Roseverne L, Alzaabi S, Maher R, Mann G, Blome S, Gill AJ, Samra JS, Mittal A.

HPB (Oxford). 2019 May;21(5):604-611. doi: 10.1016/j.hpb.2018.09.014. Epub 2018 Oct 28.

PMID:
30377050
47.

Defining Physiological Normoxia for Improved Translation of Cell Physiology to Animal Models and Humans.

Keeley TP, Mann GE.

Physiol Rev. 2019 Jan 1;99(1):161-234. doi: 10.1152/physrev.00041.2017. Review.

PMID:
30354965
48.

The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.

Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, Pereira AR, Armstrong BK, Drummond M, Morton RL, Scolyer RA, Menzies SW, Thompson JF, Cust AE.

Australas J Dermatol. 2019 May;60(2):118-125. doi: 10.1111/ajd.12928. Epub 2018 Oct 9.

PMID:
30302753
49.

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.

Chin-Lenn L, De Boer RH, Segelov E, Marx GM, Hughes TM, McCarthy NJ, White SC, Foo SS, Rutovitz JJ, Della-Fiorentina S, Jennens R, Antill YC, Tsoi D, Cronk MF, Lombard JM, Kiely BE, Chirgwin JH, Gorelik A, Mann GB.

Asia Pac J Clin Oncol. 2018 Dec;14(6):410-416. doi: 10.1111/ajco.13075. Epub 2018 Sep 30.

PMID:
30270527
50.

Analysis of recurrence after the resection of pancreatic neuroendocrine tumors.

Chouliaras K, Newman NA, Shukla M, Swett KR, Levine EA, Sham J, Mann GN, Shen P.

J Surg Oncol. 2018 Sep;118(3):416-421. doi: 10.1002/jso.25146.

PMID:
30259518

Supplemental Content

Support Center